Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Gastric HER2/Claudin18.2

Kohei Shitara

MD, PhD

🏢National Cancer Center Hospital East🌐Japan

Chief, Department of Gastrointestinal Oncology

82
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Kohei Shitara is a global leader in gastric cancer targeted therapy and immunotherapy clinical trials. He has been instrumental in advancing zolbetuximab and trastuzumab deruxtecan in gastric cancer, leading pivotal trials that reshaped treatment paradigms. His work on Claudin 18.2-directed therapy helped establish a new therapeutic target in gastroesophageal cancers.

Share:

🧪Research Fields 研究领域

Gastric cancer
HER2-targeted therapy
Claudin 18.2
Zolbetuximab
GI immunotherapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Kohei Shitara 的研究动态

Follow Kohei Shitara's research updates

留下邮箱,当我们发布与 Kohei Shitara(National Cancer Center Hospital East)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment